NEW YORK, Nov. 17, 2020 /PRNewswire-PRWeb/ -- The World Parkinson Coalition (WPC) is launching its first ever WPC Dual Language webinar program in English and Spanish. This series is designed to help prepare the non-medical and non-research Parkinson's community members to attend and actively participate alongside scientists and clinicians at the 6th World Parkinson Congress in Barcelona, Spain in June 2022.
The WPC hosts the most unique international scientific conference in the Parkinson's space. Every three years at the World Parkinson Congress, the WPC brings together basic scientists, neurologists, general physicians, nurses, rehab specialists, clinicians, as well as people with Parkinson's (PwP) and care partners to learn about Parkinson's, build collaborations, and expand our understanding of a disease that impacts more than 10 million people worldwide, 300,000 of whom live in Spain.
"The World Parkinson Congress is a scientific meeting unlike any other Parkinson's gathering," said Elizabeth Pollard, WPC Executive Director. "It's important that when non-health professionals arrive at the Congress, some of them for the first time at a scientific meeting, that they are educated and prepared for the talks so they can participate fully and walk away with an even greater knowledge than when they arrived."
Parkinson's knows no boundaries, and many people living with PD who speak Spanish find it difficult to find high level educational information about Parkinson's from trusted sources in their native language. This series will include top-notch presenters, covering key topics, in both languages, offering equitable resources.
Presenters in the series are bi-lingual experts in Parkinson's with decades of clinical and research experience. The series will continue to grow in 2021 with additional topics and presenters. Each webinar set will have two 1-hour webinars. The first webinar will be in English, followed by a short break. When the speakers return, the webinar will be presented again in Spanish.
Registration and details can be found at https://www.worldpdcoalition.org/webinarseries
Webinar #1: Lightheadedness and Parkinson's
Date: Wednesday, Dec 2, 2020
Webinar #2: Deep Brain Stimulation - Part 1
Date: Thursday, Dec 10, 2020
Webinar #3: Deep Brain Stimulation – Part 2
Date: Thursday, Jan 21, 2021
Panelists to include:
Horacio Kaufmann, MD, FAAN, Dysautonomia Center at NYU Langone Health
Patricio Millar Vernetti, MD, Dysautonomia Center at NYU Langone Health
Mariella Graziano, BSc, PT
Gonzalo J. Revuelta, DO, Medical University of South Carolina
Adolfo Ramirez-Zamora, MD, University of Florida
Francisco Ponce, MD, Barrow Neurological Institute
Adriana M. Strutt, PhD, ABPP-CN, Baylor College of Medicine
"Being a part of this new virtual bi-lingual Parkinson's series is exciting," said Dr. Horacio Kaufmann, the Axelrod Professor of Neurology at NYU School of Medicine in New York. "It shows the strong commitment of the WPC to reach patients all around the world. I would not be surprised if the next series includes Chinese, and of course Catalan."
Learn more about and register for talks in the series at https://www.worldpdcoalition.org/webcast
This webinar series is being launched with support from Theravance Biopharma, Boston Scientific, and Medtronic.
About the World Parkinson Coalition® and WPC 2022
The World Parkinson Coalition Inc. provides an international forum for learning about the latest scientific discoveries, medical practices, caregiver initiatives and advocacy work related to Parkinson's disease. The triennial World Parkinson Congresses provide a space for the global Parkinson's community of researchers, clinicians, health care professionals, people with Parkinson's and their care partners to meet in person, network, and discuss advances in Parkinson's research, improve understanding and promote advocacy worldwide, while influencing future research and care options. The WPC 2022 will attract more than 4,500 delegates.
About Parkinson's Disease
Affecting nearly one million Americans and 10 million people worldwide, Parkinson's disease is the second-most common neurodegenerative disease after Alzheimer's. There is no cure for Parkinson's and 60,000 new cases are diagnosed each year in the United States alone.
Media Contact
Kathleen Jordan, World Parkinson Coalition, +1 6463887688, [email protected]
SOURCE World Parkinson Coalition
Share this article